Cocrystal pharma, inc. (COCP)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
Revenues:
Collaboration revenue

461

402

492

592

5,078

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Grant Revenues

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

24

27

27

-

0

0

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

Sales

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-13,156

4,734

4,912

3,510

3,306

3,930

2,570

2,797

4,515

3,142

Cost of sales

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,827

2,881

2,064

4,887

1,845

1,687

1,499

2,400

1,496

Gross profit

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-5,382

1,906

2,030

1,445

-1,581

2,085

883

1,298

2,115

1,646

Operating expenses:
Selling expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

59

242

221

-

212

147

-

-

-

Selling expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

138

-

-

Depreciation expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

87

-

Depreciation expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

80

Research and development

1,283

958

1,077

1,091

878

1,204

1,467

1,119

877

965

1,393

1,393

2,071

93,876

2,093

2,368

3,342

41,578

2,177

1,946

1,560

1,350

866

888

967

927

950

980

1,005

-94

155

206

221

300

4

53

64

54

44

General and administrative

1,139

1,266

1,223

1,051

1,323

1,197

952

1,013

1,190

-44

717

717

1,050

511

-199

1,836

1,992

2,795

1,437

1,898

635

320

353

499

565

60

55

51

53

-2,200

1,352

1,318

1,593

-748

4,084

1,142

992

1,684

1,328

Total operating expenses

2,422

48,327

2,300

2,142

2,201

56,306

2,419

2,132

2,067

921

2,110

2,110

3,121

94,387

1,894

4,204

5,334

44,373

3,614

3,844

2,195

1,670

1,219

1,387

1,532

987

1,005

1,031

1,058

-2,818

1,567

1,767

2,036

-267

4,301

1,342

1,195

1,826

1,453

Income (loss) from operations

-1,961

-47,925

-1,808

-1,550

2,877

-56,306

-2,419

-2,132

-2,067

-921

-2,110

-2,110

-3,121

-94,387

-1,894

-4,204

-5,334

-44,373

-3,590

-3,817

-2,168

-1,661

-1,219

-1,387

-1,532

-987

-1,005

-1,031

-1,058

-2,563

338

262

-591

-1,313

-2,216

-459

102

288

192

Interest expense, net

-2

-3

-5

-5

-6

-3

1

-24

-32

-

-

-2

-

-

-

-

-

-

45

44

44

-

50

0

0

-

0

1

0

-

-

-

-

-

-

-

-

-

-

Interest income (expense), net

-

-

-

-

-

-

-

-

-

-

-2

-

-

-13

51

39

49

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4

2

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

Gain on settlement of mortgage note receivable

-

-

-

-

-

0

0

0

106

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest income (expense)

-

-

-

-

-

-

-

-

-

-

-

-

2

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain on disposal of mortgage note receivable

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on disposal of property and equipment

-

-

-

-

-

-

-61

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on return of escrowed shares

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

Interest expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-260

-482

-1,014

-3,472

-741

-283

-108

-109

-123

-94

Fair value of warrant liabilities in excess of proceeds from financing

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-946

-

0

0

0

-

-

-

-

-

-

-

-

-

-

Loss on return of escrowed shares

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-584

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on return of escrowed shares, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of derivative liabilities

-27

83

33

40

100

-103

129

259

21

632

-148

-148

571

430

-38

938

1,273

-

-

-

-14,418

-

-792

5,639

2,106

-

0

0

0

-324

21

37

418

-281

0

0

0

-

-

Realized gain (loss) on marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-1,685

-

-

0

480

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

Other income (expense), net

-

-

-

-

-

-

-

-

-

-

0

-

-

-

0

977

1,322

-

1

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total other income (expense), net

-29

80

28

35

94

-104

68

235

95

496

-150

-150

573

-

13

-

-

-

-

-

-14,374

-

-1,330

6,117

1,160

-

0

1

0

-

-

-

-

-

-

-

-

-

-

Equity in loss of unconsolidated subsidiary

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-6

-

-

Loss before income taxes

-

-

-1,780

-1,515

-

-56,410

-2,351

-1,897

-1,972

-425

-2,260

-2,260

-2,548

-

-1,881

-3,227

-

-

-

-

-

-

-

-

-

-

-

-

-

-3,148

-122

-714

-3,646

-2,372

-2,499

-568

-13

164

98

Change in fair value of warrants for the year ended December 31, 2014

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,036

2,887

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total other income (expense), net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,082

1,246

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

Loss before income taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-508

-2,571

-

-

-2,549

4,730

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Income tax benefit

-

-

-

-

-

-12,126

-483

-554

-419

-6,880

0

0

0

-

0

0

-

-

0

52

-

-

-

-

-

-

-

-

-

0

0

0

0

3

0

0

0

92

-40

Income tax expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

Loss from continuing operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-122

-

-

-

-

-

-

-

-

Loss from discontinued operations, net of taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

23

-

-

-

-

-

-

-

-

Net income (loss) including noncontrolling interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

256

58

Less: Net income (loss) attributable to noncontrolling interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-0

Net income (loss)

-1,990

-47,845

-1,780

-1,515

2,971

-44,284

-1,868

-1,343

-1,553

6,455

-2,260

-2,260

-2,548

-65,754

-1,881

-3,227

-4,012

-30,449

-508

-2,623

-16,542

-1,908

-2,549

4,730

-372

-794

-1,005

-1,030

-1,058

-3,505

-98

-714

-3,646

-2,375

-2,499

-568

-13

256

58

Net loss

-1,990

-47,845

-1,780

-1,515

2,971

-44,284

-1,868

-1,343

-1,553

6,455

-2,260

-2,260

-2,548

-65,754

-1,881

-3,227

-4,012

-30,449

-508

-2,623

-16,542

-1,908

-2,549

4,730

-372

-794

-1,005

-1,030

-1,058

-3,505

-98

-714

-3,646

-2,375

-2,499

-568

-13

256

58

Net loss

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-2,623

-16,542

-

-2,549

4,730

-372

-

-1,005

-1,030

-1,058

-

-

-

-

-

-

-

-

-

-

Unrealized gain on marketable securities, net of tax

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

744

-980

-2,075

408

3,354

-1,451

0

0

0

0

-

-

-

-

-

-

-

-

-

-

Total comprehensive income (loss)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,879

-17,522

-3,983

-2,141

8,084

-1,823

-794

-1,005

-1,030

-1,058

-

-

-

-

-

-

-

-

-

-

Net loss per common share:
Net income (loss) per common share, basic and diluted

-0.05

-1.50

-0.06

-0.05

0.10

-1.58

-0.06

-0.05

-0.06

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.00

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss per common share from continuing operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.00

-

-

-

-

-

-

-

-

Net income per common share from discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.00

-

-

-

-

-

-

-

-

Loss per share, basic

-

-

-

-

-

-

-

-

-

-

0.00

-0.09

-0.11

-3.17

0.00

0.00

-0.01

-2.36

0.00

0.00

-0.04

-

-0.01

0.01

-

-0.01

-0.02

-0.02

-0.02

-0.06

0.00

-0.01

-0.06

-0.06

-0.04

-0.01

0.00

0.01

0.00

Weighted average number of common shares outstanding, basic

41,662

-

-

31,621

30,337

-

-

27,716

24,384

-

728,032

24,268

23,801

-2,013,811

707,478

704,256

696,149

82,217

694

692

439

-

327

326

-

-

-

57

57

-

-

-

-

-

-

-

-

-

-

Loss per share, fully diluted

-

-

-

-

-

-

-

-

-

-

0.00

-0.09

-0.11

-3.29

0.00

0.00

-0.01

-2.34

-0.01

-0.01

-0.04

-

-0.01

0.01

-

-0.01

-0.02

-0.02

-0.02

-

-

-

-

-

-

-

-

-

-

Weighted average number of common shares outstanding, diluted

41,662

-

31,621

31,621

30,371

-

29,923

27,716

24,384

-

728,032

24,268

23,801

-2,016,224

707,478

705,606

697,272

82,210

696

696

439

-

327

326

-

-

-

57

57

61,634

69,418

59,104

56,366

48,140

67,492

41,388

44,749

-

-

Weighted average number of common shares outstanding, basic and diluted

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

32,447

-

57

-

-

-

-

-

-

-

-

-

-

-

-

Basic and diluted weighted average common shares outstanding

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

37,698

37,698

Collaboration Revenue [Member]
Total Revenues

-

-

492

592

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-